Get notified when IONS files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: IONS IONIS PHARMACEUTICALS INC 8-K

Ionis reaffirms full-year 2026 guidance, signaling on-track execution

Filed July 10, 2026 · Period ending July 9, 2026 · ~1 min read

Key Changes

  • medium

    Company reaffirms FY2026 financial guidance unchanged from April 29, 2026 first-quarter earnings release, indicating business is tracking to plan with no material developments requiring adjustment.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SLP 10-Q) is open in full — no account needed.

Partner

Trade IONS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 13, 2026 · How we verify